Physician profile
Christopher Aaron Hess
NPI 1356631162
$20,006.86
in general payments reported to CMS, 2019-2025
36 companies · $9,832 in 2025
The $9,832 reported for 2025 was more than what 99% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $878 · 2020: $473 · 2021: $647 · 2022: $1,843 · 2023: $4,277 · 2024: $2,057 · 2025: $9,832.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,838 · Food and Beverage: $6,637 · Travel and Lodging: $1,691.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,837.50 |
| Food and Beverage | $6,637.03 |
| Travel and Lodging | $1,691.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $8,021.13 | 2025 | Evoke |
| Boston Scientific Corporation | $6,787.09 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Superion Indirect Decompression System |
| Abbott Laboratories | $1,357.32 | 2019-2025 | Proclaim, Eterna, Octrode |
| Medtronic, INC. | $571.15 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Vanta Adaptivestim |
| Nevro Corp. | $512.58 | 2019-2023 | Senza |
| Abbvie INC. | $392.27 | 2023-2025 | |
| Relievant Medsystems, INC. | $386.89 | 2022-2023 | Intracept |
| Globus Medical, INC. | $271.35 | 2025 | Senza |
| Medtronic USA, INC. | $267.47 | 2019-2020 | |
| Horizon Therapeutics Plc | $242.80 | 2019-2020 | |
| Amneal Pharmaceuticals LLC | $144.33 | 2023 | Lyvispah |
| Si-Bone, INC. | $104.07 | 2022-2025 | |
| Lilly USA, LLC | $98.45 | 2019-2023 | Reyvow, Emgality |
| Allergan, INC. | $85.71 | 2019-2022 | |
| Vertex Pharmaceuticals Incorporated | $84.18 | 2024-2025 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertos Medical, INC. | $62.41 | 2023-2024 | Mild Device Kit |
| Azurity Pharmaceuticals, INC. | $55.79 | 2024-2025 | Horizant |
| Spr Therapeutics, INC | $54.94 | 2023-2025 | Sprint Pns System |
| Novartis Pharmaceuticals Corporation | $49.00 | 2019 | |
| Assertio Therapeutics, INC. | $43.07 | 2019 | |
| Alexion Pharmaceuticals, INC. | $41.90 | 2025 | Ultomiris |
| Virtus Pharmaceuticals LLC | $41.84 | 2025 | Levorphanol Tartrate |
| Arbor Pharmaceuticals, INC. | $40.88 | 2020-2021 | |
| Collegium Pharmaceutical, INC. | $40.53 | 2019 | |
| Merz Pharmaceuticals, LLC | $40.14 | 2024 | Xeomin |
| Novo Nordisk INC | $34.13 | 2024 | Wegovy |
| Lundbeck LLC | $30.67 | 2025 | Vyepti |
| Almatica Pharma LLC | $25.22 | 2021 | |
| Pfizer INC. | $22.12 | 2023 | |
| Stryker Corporation | $17.97 | 2025 | Mild Device Kit |
| Pacira Pharmaceuticals Incorporated | $17.49 | 2025 | Iovera, Exparel, Zilretta |
| Nalu Medical, INC. | $16.64 | 2021 | |
| Avanos Medical | $12.70 | 2019 | |
| Zyla Life Sciences, INC. | $12.51 | 2020 | |
| Bsn Medical INC | $12.22 | 2019 | |
| Pajunk Medical Systems, LP | $7.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Hess listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.